This review discusses the developments and current role of beta-blockers in decreasing cardiac morbidity and mortality in peri-operative medicine.
May inform individualized perioperative beta-blocker decisions; leaves open definitive recommendations pending new trials.
Beta-blockers have emerged as one of the key therapeutic agents that can decrease cardiac morbidity and mortality. Advances in cardiac beta-adrenergic receptor physiology and pharmacology have provided new insights into the beneficial effects of beta-blockers in cardiovascular medicine. Although significant advances have been made, many specific questions still remain to be answered. We will review some of these developments and the current role of beta-blockers in peri-operative medicine.
No takes yet. Share an insight, caveat, or question.
Akhtar et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: